Noida

HLL Lifecare invites REGIONAL SALES MANAGER (SENIOR MANAGER / MANAGER) | 5 posts

HLL Lifecare Limited, a Mini Ratna Central Public Sector Enterprise under the Ministry of Health & Family Welfare, Govt. of India is a global provider of high quality healthcare products & services. With state-of-the-art manufacturing facilities spanning across India, HLL is diversifying into vaccine manufacturing, lifecare services, sanitary napkins besides engaging in procurement consultancy, healthcare infrastructure development and facility management.

Post: REGIONAL SALES MANAGER (SENIOR MANAGER / MANAGER)

PLAGIARISM: A GROWING CONCERN IN SCIENTIFIC COMMUNITY

{ DOWNLOAD AS PDF }

Let us first of all know about plagiarism and how it is different from copyright piracy. Plagiarism word is derived from Latin word plagiaries which mean stealing someone else’s work1. According to oxford dictionaries its literal meaning is “the practice of taking someone else’s work or ideas and passing them off as one’s own”2. Wikipedia defines plagiarism as “the wrongful appropriation and purloining and publication of another author's language, thoughts, ideas, or expressions, and the representation of them as one's own original work”1. The word plagiarism is different from copyright piracy3. Copyright piracy is unauthorised doing anything, the exclusive right to do which is with copyright owner or reproduction, sale or hiring in any form4,5 whereas plagiarism is the failure of giving credit to original author5 but both are infringements of copyright (under Indian Copyright Act, 1957) and hence crime. Unauthorised reproduction, sale or hiring is not infringement of copyright after expiry of the copyright protection period which varies nation-wise (minimum requirement under Berne Convention is 50 years and 60 years in case of India, post mortem of copyright owner) but under author’s moral rights his authorship and control over the work is forever and no one can represent it as his/her own original work6. If someone is doing so it would be plagiarism and hence serious ethical offense and crime.

Opportunity as Business Development Manager - Health Sciences Education & Training in Tenet Health Edutech (Cliniminds)

Cliniminds is India's one of the most prestigious clinical research, health sciences, pharmacovigilance and healthcare education and training company. Cliniminds has over 50 employees and have presence in over 12 cities in India and 3 international locations.

Post: Business Development Manager - Health Sciences Education & Training

Vacancy for Manager Business Analyst in UnitedHealth Group

At UnitedHealth Group, their mission is to help people live healthier lives. To achieve this goal, they are focused on building a modern, adaptable, innovative and inclusive system of health care services.
Their scale and potential to improve health makes them one of the most visible stewards of America’s vast health care system. Entrusted with both important resources and responsibilities, they are involved on a daily basis in decision-making that has life-changing consequences for millions of Americans.

41st Annual Conference Of Research Society for study of Diabetes in India RSSDI 2013

RSSDI Annual Scientific Meetings provide a wonderful opportunity to all of us, to meet and interact with each other and share our research, knowledge and clinical experience in all facets of diabetes care. RSSDI-2013 will be yet another enriching scientific experience, where we shall strive hard to meet the expectations of clinicians and researchers alike.

Work as PROFESSIONAL SERVICE REPRESENTATIVES, AREA MANAGER in Karnataka Antibiotics & Pharmaceuticals Ltd.

Karnataka Antibiotics & Pharmaceuticals Ltd., (KAPL) Bangalore is a Government Enterprise.  From a modest beginning in 1984, KAPL has grown from strength to strength in the areas of manufacturing and marketing of various life saving and essential drugs. With an ISO accredition from KPMG, Netherlands, KAPL is recognised for its total commitment to quality and services in domestic and international markets. On profit from inception, KAPL facilities are approved by many international clients.

Work as Zonal Sales Manager, Regional Sales Manager in Systopic

We are an established Pharmaceutical Company having a committed team of 825 professionals across the country. Having created a position for ourselves among Top 35 Pharmaceutical Companies prescription wise, we are further strengthening our presence in potential specialty areas -Cardiovascular and Anti-Diabetic Segments. For our expansion programme we require:

A REVIEW ON: HYPERTENSION

ABOUT AUTHORS:
*1Akanksha baranwal, 2Akanksha Sharma, 3Anamika singh
1,3Department of pharmacology
2Department of clinical research
Noida Institute of Engineering and Technology
*akankshabaranwal1990@gmail.com

Abstract
The purpose of this review is to provide a basic understanding of the important relationship between microvascular remodelling, angiogenesis and hypertension, that is, provide an overview of recent experimental and clinical evidence from anti-hypertensive and pro- and anti-angiogenic therapy with respect to hypertension and microvascular structure. Microvascular rarefaction, that is, a loss of terminal arterioles and capillaries, is found in most forms of human and experimental arterial hypertension. This further increases peripheral resistance, and aggravates hypertension and hypertension-induced target organ damage. In some cases with a genetic predisposition, hypertension is preceded by a loss of microvessels. Therefore, new therapies aimed at reversing microvascular rarefaction potentially represent candidate treatments of hypertension. The microvasculature is formed by the continuous balance between de novo angiogenesis and microvascular regression. Imbalanced angiogenesis, in addition to functional shut-off of blood flow, contributes to microvascular rarefaction. Numerous clinical trials assessing anti-angiogenic agents in cancer patients show that this therapy leads to microvascular rarefaction and causes or aggravates hypertension. The development of specific pro-angiogenic treatment to correct hypertension or ischaemic disorders, however, it is still in its infancy. On the other hand, long-term treatment by classic anti-hypertensive therapies that present vasodilator activity can correct for hypertension-associated rarefaction in man.


Pages